Shah Investors Home Ltd
- Market Cap ₹ 291 Cr.
- Current Price ₹ 137
- High / Low ₹ 180 / 128
- Stock P/E 24.5
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 13.5 %
- ROE 8.86 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 9.57% over past five years.
- Company has a low return on equity of 12.3% over last 3 years.
- Dividend payout has been low at 11.5% of profits over last 3 years
- Debtor days have increased from 80.2 to 137 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Capital Markets Stockbroking & Allied
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 45 | 61 | 53 | 75 | 92 | 71 | |
| Sales growth | +35% | -13% | +42% | +23% | -23% | |
| 29 | 37 | 38 | 51 | 57 | 47 | |
| Operating Profit | 17 | 24 | 14 | 24 | 35 | 24 |
| OPM % | 37% | 39% | 27% | 33% | 38% | 34% |
| 4 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 1 | 2 | 5 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 19 | 22 | 13 | 21 | 29 | 18 |
| Tax % | 23% | 23% | 20% | 26% | 25% | 25% |
| 15 | 17 | 10 | 16 | 22 | 14 | |
| EPS in Rs | 9.37 | 10.97 | 6.42 | 9.86 | 14.03 | 8.68 |
| Dividend Payout % | 5% | 0% | 0% | 10% | 7% | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | 11% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 12% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 62 | 78 | 88 | 120 | 137 | 140 |
| 4 | 0 | 2 | 4 | 6 | 18 | |
| 72 | 80 | 87 | 146 | 139 | 105 | |
| Total Liabilities | 154 | 175 | 193 | 285 | 297 | 279 |
| 12 | 11 | 19 | 20 | 20 | 22 | |
| CWIP | 0 | 0 | 0 | 0 | 1 | 2 |
| Investments | 43 | 46 | 59 | 80 | 91 | 83 |
| 99 | 118 | 115 | 186 | 186 | 172 | |
| Total Assets | 154 | 175 | 193 | 285 | 297 | 279 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 25 | 15 | 14 | 110 | -27 | -27 | |
| -24 | -2 | -22 | -1 | -17 | -6 | |
| -6 | -5 | 0 | -8 | -3 | 8 | |
| Net Cash Flow | -5 | 8 | -8 | 101 | -47 | -26 |
| Free Cash Flow | 25 | 15 | 4 | 107 | -29 | -32 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 200% | 89% | 78% | 467% | -50% | -91% |
Ratios
Standalone / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 118 | 73 | 74 | 37 | 67 | 137 |
| Inventory Days | ||||||
| Days Payable | ||||||
| Cash Conversion Cycle | 118 | 73 | 74 | 37 | 67 | 137 |
| Working Capital Days | -82 | -37 | -523 | -629 | -458 | -349 |
| ROCE % | 26% | 13% | 19% | 23% | 14% |
Documents
Announcements
-
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2026, Along With The Limited Review Report.
- Board meets November 14, 2026 to approve Q2 and half-year results; trading window closed from October 6.
-
Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of System Auditor
- Board approved Q1 results, acquired 71,857 Ficus Food Lab shares for 6.25%, and appointed auditors.
-
Announcement Under Regulation 30 Of SEBI (LODR) - Appointment Of Internal Auditor
- Board approved Q1 FY27 results, 6.25% Ficus Food Lab acquisition, and auditor appointments.
-
Announcement under Regulation 30 (LODR)-Acquisition
- Board approved Q1 FY27 results and 6.25% acquisition in Ficus Food Lab on 27 Oct 2026.
-
Results -Financial Result For June 30, 2026
- Board approved Q1 FY27 results, 6.25% stake acquisition in Ficus Food Lab, and auditor appointments.